Valeurs

If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
C-RAD B	CRADB	28. avr 2025	30.00	0.00
Cadeler	CADLRO	28. avr 2025	53.25	-1.11
CAG Group	CAG	28. avr 2025	109.00	+0.46
Camurus	CAMX	28. avr 2025	590.00	+0.17
Candles Scandinavia	CANDLEB	28. avr 2025	17.65	+6.33
Cantargia	CANTA	28. avr 2025	1.63	+0.12
Carasent	CARA	28. avr 2025	24.10	+0.82
Carbiotix	CRBX	28. avr 2025	10.85	+13.02
Cardeon	CARDEO	28. avr 2025	0.11	+9.00
Careium AB	CARE	28. avr 2025	27.90	-0.71
Case	CASE	28. avr 2025	15.40	+2.67
Castellum	CAST	28. avr 2025	114.90	-0.69
Catella A	CATA	28. avr 2025	24.40	-6.87
Catella B	CATB	28. avr 2025	29.35	-0.64
Catena	CATE	28. avr 2025	440.80	-1.78
Catena Media	CTM	28. avr 2025	2.00	-2.67
Cavendish Hydrogen	CAVENO	28. avr 2025	6.34	-2.01
Cavotec SA	CCC	28. avr 2025	15.40	-0.65
CDON	CDON	28. avr 2025	54.60	+8.33
Cedergrenska	CEDER	28. avr 2025	32.00	0.00
Cell Impact	CI	28. avr 2025	0.08	-1.06
CellaVision	CEVI	28. avr 2025	161.00	-0.86
Cereno Scientific B	CRNOB	28. avr 2025	8.12	+1.50
ChargePanel AB (publ)	CHARGE	28. avr 2025	1.29	+7.02
Checkin.com Group	CHECK	28. avr 2025	9.00	-1.32
Cheffelo	CHEF	28. avr 2025	45.35	-0.87
Chordate Medical Holding	CMH	28. avr 2025	5.56	-4.14
Chordate Medical Holding Pref	CMHPREF	28. avr 2025	2.90	0.00
Chosa Oncology AB	CHOSA	28. avr 2025	0.70	-11.39
Cibus Nordic Real Estate	CIBUS	28. avr 2025	161.70	-0.19

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.